At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
LEO 29102 cream +5 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Psoriasis Plaque Test Comparing LEO 29102 Cream and Its Different Combinations to Daivobet® Ointment and a Vehicle Control for the Treatment of Psoriasis Vulgaris
In Brief
A Phase 2 clinical trial evaluating LEO 29102 cream, LEO 29102 Cream Vehicle, and 4 other interventions for Psoriasis Vulgaris. Completed, enrolled 24 participants across 1 site.
Detailed Summary
The purpose of this trial is to evaluate the anti-psoriatic effect of LEO 29102 cream and its combination with calcipotriol and betamethasone using a psoriasis plaque test method.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis Vulgaris
CountriesFrance
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2009
First PostedApr 2009
Primary CompletionMay 2009
Study CompletionJul 2009
TodayJul 2026
First PostedApr 3, 2009
Enrollment StartApr 1, 2009
Primary CompletionMay 1, 2009
Study CompletionJul 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 17.2 years ago
Interventions
LEO 29102 creamdrug
LEO 29102 Cream Vehicledrug
Betamethasone Dipropionate Creamdrug
LEO 29102 Plus Calcipotriol Creamdrug
LEO 29102 Plus Betamethasone Dipropionatedrug
Daivobet® Ointmentdrug